Atlas Trials

EGFR Mutation-Positive Lung Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR Mutation-Positive Lung Cancer

RecordFirmDate
Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study (NCT06728865)Li-kun Chen2024-09-04

Track EGFR Mutation-Positive Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.